NFE2L2 and obstructive sleep apnea syndrome: Exosomal miRNA-630 was reported to be a putative key mediator of endothelial function and cardiovascular disease risk in children with OSA, probably through targeting nuclear factor erythroid-2-related factor (Nrf2), AMP kinase, and tight junction pathways [27].